Whalegun
Lobbying

Diabetes Technology Access Coalition's latest lobbying report covers Q2 2026, at $110K. The four quarters Q3 2025–Q2 2026 total $400K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

Diabetes Technology Access Coalition

Latest quarter
$110K
Q2 2026 · 1 reports
Last 12 months
$400K
Last 4 quarters
vs last quarter
0.0%
Q2 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Diabetes Technology Access Coalition lobbying by quarter
Diabetes Technology Access Coalition lobbying by quarter
QuarterAmountReports
Q4 2022$20K1
Q1 2023$20K1
Q2 2023$20K1
Q3 2023$20K1
Q4 2023$20K1
Q1 2024$20K1
Q2 2024$20K1
Q3 2024$20K1
Q4 2024$60K1
Q1 2025$60K1
Q2 2025$60K1
Q3 2025$90K1
Q4 2025$90K1
Q1 2026$110K1
Q2 2026$110K1

Policy issues the reports name

  • Health issues15 reports
  • Medicare and Medicaid15 reports

A report that names several issues counts once for each.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)15 reports
  • Health & Human Services, Dept of (HHS)15 reports
  • HOUSE OF REPRESENTATIVES8 reports
  • SENATE8 reports
  • Office of Management & Budget (OMB)3 reports

Firms it paid

Firm
Alston & Bird$740K15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/20for Q2Alston & Bird$110K
04/20for Q1Alston & Bird$110K
01/20for Q4 2025Alston & Bird$90K
25/10/20for Q3 2025Alston & Bird$90K
25/07/21for Q2 2025Alston & Bird$60K
25/04/21for Q1 2025Alston & Bird$60K
25/01/21for Q4 2024Alston & Bird$60K
24/10/21for Q3 2024Alston & Bird$20K
24/07/22for Q2 2024Alston & Bird$20K
24/04/22for Q1 2024Alston & Bird$20K
24/01/22for Q4 2023Alston & Bird$20K
23/10/20for Q3 2023Alston & Bird$20K
23/07/19for Q2 2023Alston & Bird$20K
23/04/20for Q1 2023Alston & Bird$20K
23/01/20for Q4 2022Alston & Bird$20K